HCRTR1 and Cataplexy: It remains to be determined whether the selective activation of OX2R is sufficient to prevent narcoleptic symptoms including cataplexy and sleep/wake fragmentation, or additional activation of OX1R is also required in order fully to ameliorate these symptoms.